Please verify your email address to receive email notifications.
Enter your email address
We have sent you a verification email. Please check your inbox and spam folder.
Unable to send verification, please refresh and try again later.
A/Prof Simon Durrant is a clinical haematologist and medical oncologist at Icon Cancer Centre Wesley, Icon Cancer Centre Chermside and Icon Cancer Centre North Lakes. He also consults at hospitals acr ...
Kennedy, G. A., Tey, S. K., Buizen, L., Varelias, A., Gartlan, K. H., Curley, C., Olver, S. D., Chang, K., Butler, J. P., Misra, A., Subramoniapillai, E., Morton, A. J., Durrant, S., Henden, A. S., Moore, J., Ritchie, D., Gottlieb, D., Cooney, J., Paul, S. K., & Hill, G. R. (2021). A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis. Blood, 137(14), 1970–1979.
Your treatment costs may be reduced when the practitioner participates in a health fund member arrangement.
Ahpra MED0001381120
Australian Bone Marrow Donor Registry (ABMDR)
Australasian Leukaemia & Lymphoma Group (ALLG)
Royal Australasian College of Physicians (RACP)
United Kingdom Thalassaemia Society (UKTS)
Concise and verified healthcare information related to A/Prof Simon Durrant's field of practice. These cover conditions, treatments, and health products in an easy-to-read, high-quality format.